Titre :

Assessing the validity of adult-derived prognostic models for primary sclerosing cholangitis outcomes in children

Auteur(s) :

Deneau, Mark [Auteur]
Valentino, Pamela [Auteur]
Mack, Cara [Auteur]
Alqoaer, Khaled [Auteur]
Amin, Mansi [Auteur]
Amir, Achiya [Auteur]
Aumar, Madeleine [Auteur]
Auth, Marcus [Auteur]
Broderick, Annemarie [Auteur]
Diguglielmo, Matthew [Auteur]
Draijer, Laura G. [Auteur]
El-Matary, Wael [Auteur]
Ferrari, Federica [Auteur]
Furuya, Katryn [Auteur]
gottrand, Fréderic [Auteur]
Lille Inflammation Research International Center (LIRIC) - U995
Gupta, Nitika [Auteur]
Homan, Matjaz [Auteur]
Jensen, M. Kyle [Auteur]
Kamath, Binita M. [Auteur]
Kim, Kyung Mo [Auteur]
Kolho, Kaija-Leena [Auteur]
Koot, Bart [Auteur]
Iorio, Raffaele [Auteur]
Martinez, Mercedes [Auteur]
Miloh, Tamir [Auteur]
Mohan, Parvathi [Auteur]
Palle, Sirish [Auteur]
Papadopoulou, Alexandra [Auteur]
Ricciuto, Amanda [Auteur]
Saubermann, Lawrence [Auteur]
Sathya, Pushpa [Auteur]
Shteyer, Eyal [Auteur]
Smolka, Vratislav [Auteur]
Tanaka, Atsushi [Auteur]
Varier, Raghu [Auteur]
Venkat, Veena [Auteur]
Vitola, Bernadette [Auteur]
Woynarowski, Marek [Auteur]
Guthery, Stephen [Auteur]

Titre de la revue :

Journal of Pediatric Gastroenterology and Nutrition

Nom court de la revue :

J. Pediatr. Gastroenterol. Nutr.

Numéro :

70

Pagination :

e12-e17

Date de publication :

2020-01

ISSN :

1536-4801

Mot(s)-clé(s) en anglais :

primary sclerosing cholangitis
prognosis
pediatric
risk stratification
natural history

Discipline(s) HAL :

Sciences du Vivant [q-bio]

Résumé en anglais : [en]

Natural history models for primary sclerosing cholangitis (PSC) are derived from adult patient data, but have never been validated in children. It is unclear how accurate such models are for children with PSC. We utilized ...
Lire la suite >Natural history models for primary sclerosing cholangitis (PSC) are derived from adult patient data, but have never been validated in children. It is unclear how accurate such models are for children with PSC. We utilized the pediatric PSC consortium database to assess the Revised Mayo Clinic, Amsterdam-Oxford, and Boberg models. We calculated the risk stratum and predicted survival for each patient within each model using patient data at PSC diagnosis, and compared it with observed survival. We evaluated model fit using the c-statistic. Model fit was good at 1 year (c-statistics 0.93, 0.87, 0.82) and fair at 10 years (0.78, 0.75, 0.69) in the Mayo, Boberg, and Amsterdam-Oxford models, respectively. The Mayo model correctly classified most children as low risk, whereas the Amsterdam-Oxford model incorrectly classified most as high risk. All of the models underestimated survival of patients classified as high risk. Albumin, bilirubin, AST, and platelets were most associated with outcomes. Autoimmune hepatitis was more prevalent in higher risk groups, and over-weighting of AST in these patients accounted for the observed versus predicted survival discrepancy. All 3 models offered good short-term discrimination of outcomes but only fair long-term discrimination. None of the models account for the high prevalence of features of autoimmune hepatitis overlap in children and the associated elevated aminotransferases. A pediatric-specific model is needed. AST, bilirubin, albumin, and platelets will be important predictors, but must be weighted to account for the unique features of PSC in children.Lire moins >

Langue :

Anglais

Audience :

Internationale

Vulgarisation :

Non

Établissement(s) :

CHU Lille
Inserm
Université de Lille

Collections :

• Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286

Date de dépôt :

2024-01-30T10:28:33Z
2024-02-06T10:16:25Z